Becker Attorneys Close de-SPAC Merger of Mana Capital Acquisition Corp. and Cardio Diagnostics, Inc.

Becker Attorneys Close de-SPAC Merger of Mana Capital Acquisition Corp. and Cardio Diagnostics, Inc.

Becker is proud to announce the successful closing of a business combination between its SPAC client, Mana Capital Acquisition Corp. (“Mana Capital”), and Cardio Diagnostics, Inc. (“Cardio”), a pioneering precision cardiovascular medicine company at the intersection of epigenetics and artificial intelligence whose products enable improved prevention, early detection and treatment of cardiovascular disease. Corporate team members Jie Chengying Xiu, Michael Goldstein, Robert Brighton, and Valeria Angelucci represented Mana Capital during the transaction.

The transaction was approved at a special meeting of Mana Capital stockholders held on Tuesday, October 25, 2022. The combined company started trading on October 26, 2022, under the new name “Cardio Diagnostics Holdings, Inc.,” and is led by Chief Executive Officer Meeshanthini (Meesha) Dogan, Ph.D., and its current management team. The leadership team of the combined company rang the closing bell at the Nasdaq Stock Market at 4:00PM Eastern on November 3, 2022, celebrating the successful completion of the business combination.

Cardio’s mission is to help physicians better detect and treat cardiovascular disease, the leading cause of death in the United States. The core of its cardiovascular solutions is a proprietary Integrated Genetic-Epigenetic Engine™ created at the University of Iowa by company founders Meesha Dogan, Ph.D., and Robert Philibert, MD, Ph.D. This technology enables the development of a series of tests for precision prevention, early detection, and assists in personalized treatment of major types of cardiovascular diseases and associated co-morbidities.

The Benchmark Company, LLC acted as the financial advisor to Mana Capital. Shartsis Friese LLP served as legal advisor to Cardio.

Becker’s Corporate Practice Group takes pride in becoming part of our clients’ business team. We make it a priority to understand our clients’ operations and strategies, and develop solutions that include a business, legal, and regulatory perspective. The team’s collective expertise includes corporate governance, M&A, employment agreements and executive compensation, broker-dealer and investment advisor regulation, wealth and business preservation, intellectual property, SEC disclosure and securities regulation, SPACs, corporate finance, debt restructuring, bankruptcy, tax controversy, and a host of other financial service industry-related concerns.

To learn more about Becker’s Corporate Practice Group and services, please click here.